bleeding after glp 1 injection GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters GLP-1 Medications Linked to Increased

FARXIGA 10 mg as monotherapy also provided statistically significant improvements in FPG and statistically significant reduction in body weight compared with metformin alone and was non inferior to metformin XR monotherapy in lowering HbA1c Figure 2: Adjusted Mean Change from Baseline Over Time in HbA1c (%) in a 24-Week Active-Controlled Trial of FARXIGA Initial Combination Therapy with Metformin XR In a second trial (NCT00643851), 603 patients were randomized to 1 of 3 treatment arms following a 1-week lead-in period: FARXIGA 5 mg plus metformin XR (up to 2,000 mg per day), FARXIGA 5 mg plus placebo, or metformin XR (up to 2,000 mg per day) plus placebo

Waiting for enforcement action is rarely the right strategy

Missing a scheduled tirzepatide dose requires specific guidance to ensure safe resumption of therapy

There is no direct head-to-head trial, but the mechanistic difference, particularly the addition of glucagon receptor activity increasing energy expenditure, distinguishes the two compounds